Organ development is a complex process involving the coordination of cell proliferation, differentiation, and morphogenetic events. Using a screen to identify genes that function coordinately with lin-35/Rb during animal development, we have isolated a weak loss-of-function (LOF) mutation in pha-1. lin-35; pha-1 double mutants are defective at an early step in pharyngeal morphogenesis leading to an abnormal pharyngeal architecture. pha-1 is also synthetically lethal with other class B synthetic multivulval (SynMuv) genes including the C. elegans E2F homolog, efl-1. Reporter analyses indicate that pha-1 is broadly expressed during embryonic development and that its functions reside in the cytoplasm. We also provide genetic and phenotypic evidence to support the model that PHA-1, a novel protein, and UBC-18, a ubiquitinconjugating enzyme that we have previously shown to function with lin-35 during pharyngeal development, act in parallel pathways to regulate the activity of a common cellular target.
Introduction
Studies over the past 30 years have revealed the tremendous complexity in the genetic and biochemical mechanisms that control organismal development. It is now evident that in addition to being controlled by large numbers of gene products, most developmental processes are regulated by intricate networks of parallel and intersecting pathways. This facet of developmental control is underscored by the widespread phenomenon of genetic redundancy-the observation that two or more genes may perform similar or complementary biological functions. Because of such overlap, individual mutations in many genes may have little or no effect on the developmental program of the organism. In contrast, compound mutations in two or more ''redundant'' genes may produce a clear-cut ''synthetic'' phenotype. Although the full extent of genetic redundancy is not known for most organisms, studies from yeast and C. elegans indicate that a substantial fraction of genes (perhaps the majority) direct functions that are at least partially, if not largely, redundant with the activities of other genes (Fraser et al., 2000; Hodgkin, 2001; Kamath and Ahringer, 2003; Smith et al., 1996; Tong et al., 2004; Winzeler et al., 1999) . This unavoidable aspect of biology presents a continuing conceptual and technical challenge to researchers seeking to understand the complex means by which cellular and developmental processes are controlled.
One of the best-studied examples of genetic redundancy in a multicellular organism is the synthetic multivulval (SynMuv) mutants of C. elegans (Ferguson and Horvitz, 1989) . Most SynMuv genes belong exclusively to one of two classes, A or B. In general, the isolated class A and B mutations have little or no phenotype either as single mutants or when paired with other mutations from the same class. However, animals containing compound mutations in genes from both classes display a highly penetrant Muv phenotype, indicating that class A and B genes are genetically redundant (reviewed by Fay and Han, 2000) . Although the molecular functions of the class A genes are largely unknown, many class B genes encode homologs of well-studied transcriptional regulators. These include histone deacetylase (Lu and Horvitz, 1998) ; several nucleosome remodeling (NURD) components (Solari and Ahringer, 2000; von Zelewsky et al., 2000) ; a heterochromatin protein 1 homolog, hpl-2 (Couteau et al., 2002) ; efl-1, a homolog of mammalian E2F (Ceol and Horvitz, 2001) ; and the C. elegans Retinoblastoma protein (Rb) homolog, lin-35 (Lu and Horvitz, 1998) .
A large body of work, mostly from mammalian systems, has generated a model in which Rb, when bound to E2F, recruits factors that can mediate transcriptional repression (reviewed by Harbour and Dean, 2000; Kaelin, 1999; Morris and Dyson, 2001 ). These factors include histone deacetylase (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) , NURD complex components (Dunaief et al., 1994; Strober et al., 1996; Zhang et al., 2000) , and proteins associated with heterochromatin formation and maintenance (Dahiya et al., 2001; Narita et al., 2003; Nielsen et al., 2001 ). This leads to localized changes in chromatin structure and the down-regulation of E2F target genes, many of which include factors required for the initiation and execution of S phase and DNA replication (e.g., DeGregori et al., 1995; Dou et al., 1994) .
Through screens for mutations that show synthetic phenotypes with lin-35, we have previously shown that fzr-1, a conserved component of the APC ubiquitin-ligase complex, functions redundantly with lin-35 to control cell cycle exit in multiple postembryonic cell lineages of C. elegans (Fay et al., 2002) . More recently, we identified a role for lin-35 and a ubiquitin-conjugating enzyme, ubc-18, in the development of the anterior digestive tract (Fay et al., 2003) . lin-35; ubc-18 double mutants are defective at an early step in pharyngeal morphogenesis that involves a transformation in the orientation of a subset of pharyngeal cell precursors. This finding represents one of the first pieces of in vivo evidence demonstrating a role for Rb family proteins in organ morphogenesis and indicates that lin-35 may have developmental functions that are not connected to cell cycle control. Other evidence to suggest a direct role for Rb family members in tissue morphogenesis includes recent work by Ruiz et al. (2003) , demonstrating that the Rb-related proteins p107 and p130 function in the formation of hair follicles and incisors in mice. Consistent with this, microarray analyses indicate that both Rb and E2F participate in the regulation of a sizeable number of genes that are not connected to cell cycle control, including factors involved in cell adhesion, signal transduction, and pattern formation (Black et al., 2003; Dimova et al., 2003; Ishida et al., 2001; Markey et al., 2002; Muller et al., 2001; Russo et al., 2003; Vernell et al., 2003; Wells et al., 2003) . Moreover, altered expression of E2F can disrupt embryonic patterning in both C. elegans and Xenopus through mechanisms that appear to be independent of cell cycle control (Page et al., 2001; Suzuki and HemmatiBrivanlou, 2000) .
Here, we report the identification of a synthetic genetic interaction between lin-35 and mutations in the gene pha-1. Interestingly, lin-35; pha-1 double mutants show defects in pharyngeal development that appear largely identical to those observed for lin-35; ubc-18 double mutants. Moreover, we present genetic data suggesting that all three genes (lin-35, pha-1, and ubc-18) may function in parallel pathways to regulate a common molecular target.
Materials and methods

Strains and genetic methods
Maintenance, culturing, and genetic manipulations of C. elegans were carried out according to standard procedures at 16jC, 20jC, and 25jC, as indicated (Sulston and Hodgkin, 1988 [vab-7(e1562) , pha-1(e2123); myo-2:: GFP], WY131 [vab-7(e1562) , pha-1(e2123); ajm-1::GFP], WY132 [vab-7(e1562) , pha-1(e2123); pha-4::GFP-mem], MH1384 (ajm-1::GFP), SM469 (pha-4::GFP-NLS), SM481 (pha-4::GFP-mem), PD4792 (myo-2::GFP), DP132 (unc-119::GFP), GE42 [vab-7, pha-1(e2123)], and GE24 [(pha-1(e2123)]. The extrachromosomal array kuEx119 expresses both wild-type lin-35 as well as a ubiquitously expressed GFP reporter (sur-5::GFP; Fay et al., 2002) .
To generate lin-35; pha-1(fd1)/pha-1(e2123) animals, we used the following two approaches: WY125 [lin-35(n745) ; pha-1(fd1), dpy-18(e364); kuEx119] animals were crossed to lin-35 males and male cross-progeny were in turn mated to WY128 hermaphrodites. Cross-progeny animals of the correct genotype were identified as wild-type-appearing GFP+ hermaphrodites that produced wild-type, Dpy, and Vab progeny. We note that 42 of 43 F1 progeny that displayed the correct genotype generated strains that were dependent on the array (kuEx119) for viability. As an additional approach, we crossed lin-35(n745)/+; pha-1(e2123), dpy-18(e364) males to WY41 [lin-35(n745) ; vab-7(e1562), pha-1(fd1); kuEx119] hermaphrodites and identified the correct cross-progeny as wild-type GFP+ hermaphrodites that produced wild-type, Dpy, and Vab progeny and were dependent on the array (kuEx119) for viability.
Strains used to map fd1 include WY64 [lin-35(n745); vab-7(e1562), unc-71(e541) @278,a,62; and yy48e02.s1@180,a,62; and to the right of SNP yy44f01.s1@168,g,59. Through sequencing of the CB4856 strain, we identified additional SNPs to place fd1 to the right of the following polymorphism: a 10-bp insertion (CTAAAAAAAT) in CB4856 between nucleotides 25,625/25,626 of sequencing contig Y48A6C. fd1 was also placed to the left of the following polymorphisms in sequencing contig Y47D3A: G!T at position 35,344; C!T at 34,250; C!A at position 34,238; G!A at 32,935; and T!C at 32,854. This last polymorphism, along with the insertion at 25,625 of Y48A6C, formally defined the SNP mapping endpoints for fd1. This region spans 42,865 bp and contains five predicted open reading frames.
To test suppression of lin-35; ubc-18 by sup-36 and sup-37, dpy-13, unc-24/+ and dpy-11, unc-76/+ males were crossed into lin-35; ubc-18, unc-32; kuEx119 hermaphrodites and cross-progeny males were further crossed to sup-36 and sup-37 hermaphrodites, respectively, to generate lin-35/+; ubc-18, unc-32/+; sup-36/dpy-13, unc-24 and lin-35/ +; ubc-18, unc-32/+; sup-37/dpy-11, unc-76 hermaphrodites. ; sup-37 animals were subsequently identified as Unc (unc-32) animals that failed to segregate Dpy Unc progeny (dpy-13, unc-24 or dpy-11, unc-76) and expressed a Muv phenotype when placed on lin-15a(RNAi) plates (indicating that lin-35 was homozygous). Finally, candidate strains were sequenced by PCR amplification to verify the presence of the homozygous ubc-18(ku354) molecular lesion (Fay et al., 2003) .
Other methods pha-1 rescue
Rescue of lin-35; pha-1(fd1) synthetic lethality was obtained by injecting a mixture of plasmid pBX (Granato et al., 1994a,b) , which contains the wild-type pha-1 gene, and pRF4, which encodes a dominant roller gene (Mello and Fire, 1995) , into WY119. Multiple non-GFP-expressing roller animals that no longer required the kuEx119 array (containing lin-35-rescuing sequences) for viability were then identified in subsequent generations.
RNAi
RNAi was carried out according to standard methods (Fire et al., 1998; Fraser et al., 2000) . Feeding vectors were constructed as previously described (Fay et al., 2002 (Fay et al., , 2003 . For pha-1 RNAi, a fragment spanning nucleotides 759 -1424 of the pha-1 cDNA was subcloned into the polylinker of pPD129.36. RNAi inactivation of pha-1 (by feeding methods) substantially reduced, but did not abolish expression of the pha-1::GFP reporter, indicating that reduction of pha-1 activity by this method is incomplete.
GFP reporter constructs
To express a functional PHA-1::GFP fusion protein, a genomic sequence containing approximately 2.9 kb of pha-1 upstream regulatory sequences (from nucleotide position 28,395 of Y48A6C to the pha-1 start codon at position 31,284) along with the pha-1 genomic coding region (minus the C-terminal 8 aa) was fused in frame to GFP (at the C terminus of PHA-1). This construct (40 ng/Al) was injected into N2 animals along with pRF4 (100 ng/Al) and herring sperm DNA (30 ng/Al; as a carrier) to generate strains carrying stable extrachromosomal arrays. This expressed fusion construct was determined to be functional based on its ability to suppress the lethality of pha-1(e2123) mutants (at 25jC). Similar expression patterns were also observed using reporter constructs containing approximately 2.9 kb of upstream regulatory sequences together with genomic sequences encoding the first 137 aa of PHA-1 fused to a GFP containing a nuclear localization signal.
Computational analyses
The following Internet sites were used in our analysis of the PHA-1 peptide sequence: (Avery, 1993 Fay et al., 2003) . The pharynges in these animals were markedly shortened as compared with wild type (Figs. 1C, D) and did not form a functional connection to the mouth or buccal cavity (termed the Pun phenotype, for pharynx unattached). Upon hatching, such animals starved because of an inability to feed. Other larval-arrested double mutants showed more subtle defects such as irregular or indistinct pharyngeal contours (data not shown), which probably result in pharyngeal malfunction. The large adult (black arrowhead) with GFP fluorescence is of genotype lin-35; pha-1(fd1); kuEx119. The small, growth-retarded adults (white arrowheads) and arrested larva (white arrow) are of genotype lin-35; pha-1(fd1). Inset in A and B shows an arrested L1 larva (black arrow) of genotype lin-35; pha-1(fd1); kuEx119 that was treated with lin-35(RNAi). (C, D) Wild-type, (E) lin-35; pha-1(fd1), and (F) pha-1(e2123) (at 25jC) L1 larvae expressing myo-2::GFP (insets E, F), which serves as a marker for pharyngeal muscle cell differentiation. Black and white arrowheads, posterior and anterior pharyngeal boundaries, respectively; black arrows, the pharyngeal lumen. Note the abnormal shape but clear expression of the myo-2::GFP reporter in the lin-35; pha-1(fd1) and pha-1(e2123) larvae. (G) Representative pha-1(e2123) (at 25jC) terminally arrested embryos showing morphogenetic defects in the pharynx as well as overall body plan. Black arrows indicate pharyngeal lumens. Note that the embryo in the upper right appears to have a 'fully' extended pharynx (arrowheads), but still shows strong defects in body morphogenesis, indicating that gross morphogenetic defects are not a secondary consequence of failed pharyngeal extension. Scale bars: A, 100 Am for A, B; C, 10 Am for C -F; G, 10 Am for G.
In contrast to the double mutants, fd1 single mutants were largely healthy with normal pharynges and brood sizes that were similar to those of wild type (Table 1) . We did, however, observe a low incidence of larval lethality in fd1 single mutants (Table 1) . These larvae had normal-appearing pharynges but arrested with a ''fluidfilled'' morphology that has been reported for many mutants, including hypomorhic alleles of genes comprising the Ras/MapK signaling pathway (Han and Sternberg, 1990; Yochem et al., 1997) . This phenotype has been associated with defects in the excretory system, which functions in C. elegans osmoregulation (Nelson and Riddle, 1984) . We note that this class of larval-arrested animals was not enhanced by the absence of lin-35 function (data not shown) and could theoretically be due to a secondary mutation in a closely linked gene.
fd1 defines a partial loss-of-function mutation in pha-1 fd1 was genetically mapped using a combination of visible markers and single-nucleotide polymorphisms (SNPs) to an approximately 43-kb genomic region containing five predicted open reading frames (for details, see Materials and methods). Because cosmid-based genomic clones for use in transgenic rescue experiments were unavailable for this region, we took a reverse-genetics approach by testing the five candidate genes for synthetic lethality with lin-35 using RNA-interference (RNAi). Only one of the five genes in this region, Y48A6C.5, showed a genetic interaction with lin-35 by RNAi. Interestingly, this clone corresponds to pha-1, a gene previously implicated in pharyngeal development (also see below). Although pha-1(RNAi) (by feeding methods) had no effect on wild-type animals (Gonczy et al., 2000; Kamath and Ahringer, 2003 ; and this study), presumably due to the inefficiency of the technique (also see methods), identically treated lin-35 mutant animals either arrested as small larvae or progressed to become sterile adults (Table 1 and data not shown). Importantly, a low, but significant, percentage of arrested larvae showed pharyngeal defects including the Pun phenotype (Table 1) . As further evidence that fd1 defines an allele of pha-1, we were able to rescue the synthetic lethality of lin-35; fd1 double mutants through the expression of wild-type pha-1 from an extrachromosomal array (see Materials and methods). Based on the above findings, as well as additional results presented below, we conclude that fd1 represents a weak LOF mutation in pha-1.
To further examine the nature of the fd1 allele, we reduced pha-1 activity in lin-35; pha-1(fd1) double mutants through RNAi. As would be expected for a partial LOF mutation, RNAi of pha-1 increased the severity of the phenotype beyond that of the untreated double-mutant strain (Table 1 ). In addition, we generated strains that were homozygous for lin-35 but heterozygous for the pha-1(fd1) mutation. Although these animals did not display a Pun phenotype or arrest as larvae, we did observe an increase in sterility and a reduction in brood size, as compared with lin-35 mutants alone (Table 1) . This is likely attributable to a haploinsufficiency effect, a phenomenon we had also observed in lin-35; ubc-18/+ mutant animals (Fay et al., 2003) . Table 1 Genetic interactions between lin-35 and pha-1 All experiments were conducted at 20jC unless otherwise indicated. a Animals either died as larvae or failed to reach maturity after 5 days. b Fay et al. (2002) . c Double-mutant animals were derived from the self-progeny of lin-35; pha-1; kuEx119 hermaphrodites. Progeny that failed to segregate the array (kuEx119À) were identified by their lack of GFP expression. d For details on the construction of this strain, see Materials and methods. e Non-Vab, non-Dpy larvae, derived from lin-35; pha-1(fd1), dpy-18/vab-7, pha-1(e2123) parents, were scored for the Pun phenotype. f Heterozygous animals were obtained by mating lin-35 males to lin-35; vab-7, pha-1; kuEx119 hermaphrodites and scoring the effects in the non-Vab kuEx119À progeny.
To identify a genetic lesion, we first sequenced the coding region of pha-1 in the fd1 mutant background. Surprisingly, we failed to detect any differences from the established wild-type pha-1 sequence, including the conserved splice-junction sites. To see if a regulatory element had been altered, we sequenced >3 kb upstream of the pha-1 transcriptional start site, as well as the four introns and 3V UTR of the gene. Through this analysis, we identified a single lesion (C!T) occurring 156 bp upstream of the pha-1 start methione. This mutation was detected in six separate pooled-PCR reactions of lin-35; pha-1(fd1) and pha-(fd1) mutants, but was not present in the starting strain used to isolate the fd1 mutation, lin-35; kuEx119 (MH1461). The altered site [TATCC(C/T)TCCAG] does not correspond to consensus sequences for any known transcription factors (for details on the analysis tools used, see Materials and methods). Given the location of this mutation, a straightforward explanation is that the mutated site leads to a reduction in levels or delayed expression of the pha-1 transcript. We note that the region covered by our sequencing analysis extends several hundred base pairs past the known poly-A signal of pha-1 and includes >1 kb of upstream sequences that were previously shown to be unnecessary for complete rescue of the pha-1 null phenotype (Granato et al., 1994a) . Therefore, it is very unlikely that we have failed to identify any relevant mutations in a more distal regulatory element.
Previous work by Granato et al. (1994a) and Schnabel and Schnabel (1990) identified multiple mutations in pha-1, including the temperature-sensitive allele e2123. e2123 leads to a strong LOF phenotype in pha-1 (at the nonpermissive temperature of 25jC) and encodes an altered peptide containing a cysteine to tyrosine substitution at amino acid position 169. pha-1(e2123) mutants raised at 25jC arrest almost uniformly as embryos that contain abnormal (Pun) pharynges. In addition, these embryos often show defects in overall body morphogenesis, suggesting that pha-1 may function in the development of other tissues ( Fig. 1G ; Schnabel and Schnabel, 1990) . No obvious defects are visible in pha-1(e2123) mutants propagated at the permissive temperature of 16jC (Table 1 ; Schnabel and Schnabel, 1990) . However, we found that pha-1(e2123) mutants grown at 16jC showed a strong synthetic phenotype with loss of lin-35 function (either through mutation or RNAi; Table 1 ). Based on the percentages of Pun animals, the phenotype of lin-35; pha-1(e2123) mutants (at 16jC) appears to be more severe than that of lin-35; pha-1(fd1) animals at all temperatures (Table 1 and data not shown). Thus, the fd1 allele of pha-1 probably possesses more residual activity than the e2123 allele at its permissive temperature of 16jC.
We found that strains heterozygous for both the e2123 and fd1 alleles of pha-1 [pha-1(e2123)/pha-1(fd1)] were viable at all temperatures, consistent with fd1 encoding a weak LOF mutation. We also used a variety of methods to generate lin-35; pha-1(e2123)/pha-1(fd1) animals (see Materials and methods) to assess the ability of these alleles to complement one another in the lin-35 mutant background. As expected, lin-35; pha-1(e2123)/pha-1(fd1) mutants were nonviable and arrested primarily as larvae (Table 1) . As a control, lin-35; ubc-18(ku354)/pha-1(e2123) animals were found to be uniformly viable (Table 2) . These results further confirm that fd1 is an allele of pha-1. Somewhat surprisingly, however, lin-35; pha-1(e2123)/ pha(fd1) mutants showed a less severe phenotype (at both 16jC and 25jC) than either of the homozygous lin-35; pha-1(fd1) or lin-35; pha-1(e2123) (at 16jC) strains, based on the percentage of Pun larvae (Table 1 and data not shown). Table 2 Genetic interactions between pha-1 and ubc-18 All experiments were conducted at 20jC, unless otherwise indicated. a Animals either died as larvae or failed to reach maturity after 5 days. b Fay et al. (2003) . c Animals of this genotype were generated by crossing lin-35; ubc-18, unc-32/+ males to lin-35; vab-7, pha-1(e2123); kuEx119 hermaphrodites. Cross-progeny of the correct genotype were identified by the presence of Unc and Vab progeny in the next generation as well as by the absence of GFP expression. d Non-Vab animals, derived from lin-35; ubc-18, unc-32/vab-7, pha-1(e2123) parents, were scored for the Pun phenotype as L1 larvae. Based on percentages, 2/3 of the non-Vab larvae should be of genotype lin-35; ubc-18, unc-32/vab-7, pha-1(e2123) whereas 1/3 should be of genotype lin-35; ubc-18, unc-32. The absence of any Pun larvae is not unexpected, given that the percentage of lin-35; ubc-18 Pun animals is normally very low (see Table 2 ) and that expression of the Pun phenotype would be further diminished by the maternal rescue of ubc-18 (Fay et al., 2003) .
One possible explanation to account for this result is that the PHA-1 protein may function in vivo as a homodimer. Thus, in the mixed lin-35; pha-1(e2123)/pha-1(fd1) background, low levels of wild-type PHA-1 protein, generated by the fd1 allele, may be able form functional dimers with the more abundant e2123 PHA-1 protein product. This could lead to higher overall levels of PHA-1 dimer activity in the mixed allele strain than in homozygous lin-35; pha-1(fd1) or lin-35; pha-1(e2123) mutants.
lin-35; pha-1 mutants are defective at an early step in pharyngeal morphogenesis
To determine the underlying cause for the Pun phenotype, we analyzed three aspects of pharyngeal development in lin-35; pha-1 double mutants: (1) the generation of pharyngeal precursor cells, (2) the ability of precursor cells to undergo terminal differentiation into multiple cell types, and (3) the morphogenetic events required to form the mature organ. Conceivably, defects in any of these processes could contribute to the observed phenotypes.
Specification of pharyngeal precursor cells is first initiated during the mid-proliferative phase of embryogenesis, approximately 150 min into development (Horner et al., 1998; Sulston et al., 1983) . To detect pharyngeal precursor cells, we utilized a marker (pha-4::GFP) that is expressed in all cells destined to form the pharynx, as well as other cells comprising the digestive tract (e.g., intestinal, rectal, and arcade cells of the buccal cavity; Horner et al., 1998) . More specifically, we counted pha-4::GFP+ cells in the head region of mutant and wild-type embryos at the 1.5-fold stage of embryogenesis, at which time pharyngeal elongation has been initiated in wild-type animals ( Figs. 2A, B) . Importantly, we scored only double-mutant embryos that had clearly failed to undergo pharyngeal elongation by this stage (Figs. 2C, D) . We also note that based on the size, shape, and characteristic positions of intestinal cell nuclei, we were able to unambiguously exclude these cells from our counts.
lin-35; pha-1(fd1) double mutants showed a slight reduction in the average number of cells expressing the marker (95 F 8; n = 9; range, 80 -105) as compared with wild-type animals at this stage (100 F 3; n = 11; range, 95 -104; Figs. 2A -D ; Fay et al., 2003) . Of the nine mutant embryos analyzed, however, six contained 95 or more cells. This indicates that a large proportion (perhaps the majority) of mutant embryos contain indistinguishable numbers of pharyngeal cell precursors from wild type. Similar results were also observed in wild-type and lin-35; pha-1(fd1) mutant Pun larvae (Figs. 2E -H) . Thus, differences in the number of pharyngeal precursor cells cannot account for the observed defects in our double mutants. We note that these results are nearly identical with our findings for lin-35; ubc-18 double mutants (Fay et al., 2003) . Furthermore, our results are consistent with earlier analyses of pha-1 mutants, which detected no differences in numbers of pharyngeal precursor cells in wild-type and pha-1(e2123) mutants at 25jC (Schnabel and Schnabel, 1990) .
The Pun pharynges of lin-35; pha-1(fd1) double mutants, although abnormally shaped, displayed several characteristics that are consistent with normal tissue differentiation. These include the presence of a distinct pharyngeal lumen, suggesting the differentiation of epithelial cells (Figs. 1E, F) . In addition, we have observed sustained rhythmic pumping, a property of the pharynx in wild-type animals, in many lin-35; pha-1(fd1) Pun larvae. This finding indicates the presence of functional muscle cells and may suggest some degree of proper neuronal connectivity. In further support of these results, we have observed strong expression of several GFP markers, indicating the presence of differentiated muscle (myo-2::GFP; Okkema et al., 1993) , epithelium (ajm-1::GFP; Mohler et al., 1998) , and neurons (unc-119::GFP; Maduro and Pilgrim, 1995) in the pharynges of lin-35; pha-1(fd1) Pun mutants (Figs. 1E, F and data not shown). We also note that we found no evidence indicating that the morphogenesis defects are the direct result of a delay in the timing of pharyngeal cell differentiation (data not shown). From these data, we conclude that the terminal differentiation of three pharyngeal cell types occurs in lin-35; pha-1(fd1) double mutants. However, based on our method of analysis, we cannot know that all cells within the classes examined underwent correct terminal differentiation.
We have previously shown that lin-35; ubc-18 mutants are defective at an early step in pharyngeal morphogenesis (Fay et al., 2003) , termed ''reorientation'' (Portereiko and Mango, 2001) . At this time, a set of radially oriented anterior pharyngeal precursor cells undergoes a shift in their apical -basal polarity, such that their long axes become aligned with the dorsal ventral axis of the embryo (Fig.  3M) . Using a membrane-localized GFP reporter that is expressed under the control of the pha-4 promoter, we were able to follow this process in the double-mutant background. For technical reasons, these experiments were carried out using the e2123 allele of pha-1 (at 16jC) in combination with lin-35(RNAi). Our findings indicate that, like lin-35; ubc-18 mutants, the majority (11/16) of lin-35; pha-1 mutants examined were at least partially defective at the reorientation step of pharyngeal morphogenesis (Figs. 3A -J). Interestingly, we found that pha-1(e2123) singlemutant embryos grown at 25jC were not defective at early stages of pharyngeal morphogenesis. Rather, these embryos underwent pharyngeal elongation in an apparently normal manner to form a transient attachment to the buccal cavity (n > 100; Figs. 3K, L). At some later stage, this connection is disrupted, leading to the Pun phenotype in pha-1(e2123) mutants (Schnabel and Schnabel, 1990 ; and data not shown). These results indicate that pha-1 has both independent and overlapping functions with lin-35 during pharyngeal development, and that early pharyngeal morphogenesis is controlled specifically by the overlapping activities of these gene products.
Differentiation in pha-1(e2123) mutants
Strong LOF mutations in pha-1 were previously reported to interfere with the differentiation of multiple pharyngeal cell types (Granato et al., 1994a; Okkema et al., 1997; Schnabel and Schnabel, 1990) . Three of the cell types examined (muscle, gland, and marginal cells) failed to express terminal differentiation markers based on antibody staining, and a fourth cell type (epithelium) was inferred to be affected based on the absence (or grossly delayed appearance) of a pharyngeal lumen. Although these findings differed significantly from our own observations of lin-35; pha-1(fd1) double mutants, it was possible that our weak LOF allele of pha-1 (fd1), in combination with lin-35 LOF, was producing a qualitatively different phenotype than strong LOF mutations in pha-1. Several observations, however, suggest that cell-type-specific differentiation may occur in pha-1(e2123) mutants to a greater extent than was previously thought. First, we observed a distinct pharyngeal lumen in 98% (n = 110) of newly hatched pha-1(e2123) larvae (at 25jC; as well as most late-stage embry- os; Figs. 1G, H and data not shown). Second, we observed robust expression of the ajm-1:GFP epithelial marker beginning at the comma stage of embryogenesis and persisting into adulthood (data not shown). Third, expression of the myo-2::GFP reporter was observed in nearly all (99%; n = 64) pha-1(e2123) mutants (at 25jC), beginning at about the 3-fold stage of embyrogenesis (Figs. 1G, H and data not shown). Although the intensity of GFP staining in pha-1(e2123) mutants was somewhat reduced as compared with wild type, the onset of expression appeared to be identical. This result was surprising, as pha-1(e2123) mutants were initially reported to not express the protein product of myo-2 (Granato et al., 1994a; Schnabel and Schnabel, 1990) , based on staining patterns with MYO-2-specific monoclonal antibodies (Miller et al., 1983 (Miller et al., , 1986 . It is possible, however, that some of these differences may be attributable to an increase in the sensitivity of our GFP reporter (myo-2::GFP) vs. antibody staining. In addition, it remains possible that PHA-1 acts posttranscriptionally to promote the translation of myo-2 mRNA, thereby accounting for the discrepancy between myo-2 mRNA and protein levels.
pha-1 is widely expressed and is concentrated in the cytoplasm
To examine the expression pattern of pha-1 during development, we generated strains that express a functional ''full-length'' PHA-1::GFP fusion protein under the regulatory control of the wild-type pha-1 promoter (for details, see Materials and methods). Expression of the pha-1 reporter was first detected at the approximately 100-cell stage in all somatic cells of the embryo (Figs. 4A, B) . This pattern of widespread expression continued through later stages of embryonic development (Figs. 4C, D) , diminishing somewhat in intensity by the time of hatching. Expression was also observed in early-larval-stage animals (Figs. 4E -H) and was present but reduced in late-stage larvae and adults (data not shown). Strikingly, most if not all PHA-1::GFP fusion protein localized to the cytoplasm (Fig. 4) . This was particularly apparent in larvae, where the contribution of nonspecific GFP fluorescence coming from layers outside of the central focal plane was minimized. In addition, we saw no evidence for any dynamic regulation of PHA-1 with respect to its subcellular localization. Although these findings do not rule out the possibility that some PHA-1 protein may normally be present in nuclei, they strongly suggest that PHA-1 resides primarily, if not exclusively, in the cytoplasmic compartment. Moreover, although it was possible that the tagged fusion protein may have been mislocalized, either due to the presence of the C-terminal GFP extension, or simply through overexpression, the ability of the fusion protein to substitute functionally for wild-type PHA-1 suggests that it is localizing to the correct cellular compartment. We note that a previous report examining the expression pattern of pha-1 using a (nonfunctional) pha-1::lacZ reporter detected transient expression in only pharyngeal precursor and body wall muscle cells (Granato et al., 1994a) . Given that the regulatory regions used in these two reporter constructs were similar, these discrepancies may be attributable to differences in the stability or sensitivity of h-galactosidase vs. GFP.
pha-1 was initially suggested to encode a transcription factor of the bZIP family (Granato et al., 1994a) . This assignment was based on relatively weak sequence homologies between PHA-1 and the leucine-zipper and basic regions of seven other bZIP family members. However, as pointed out by the original authors, the spacing of these two regions in PHA-1 differed substantially from that of known bZIP proteins. Moreover, our detection of PHA-1::GFP in the cytoplasm would not be consistent with a role in transcriptional regulation. We therefore carried out a computational analysis on the predicted PHA-1 peptide to determine its probable molecular function. Our results strongly indicate that pha-1 does not encode a bZIP transcription factor. PSORT, as well as several other Internetbased analysis programs (see Materials and methods), failed to detect three domains expected to be present in all bZIP factors including a coiled-coil domain, a leucine zipper, and a nuclear localization signal. In contrast, of the remaining 18 genes in the C. elegans genome with bZIP annotations, 17 are likely to contain coiled-coil domains (confidence values z 0.6) based on these analysis tools (data not shown). Other classes of functional domains were not detected in our analysis of PHA-1, and the precise molecular function of this protein remains unclear. Nevertheless, our findings strongly indicate that pha-1 does not encode a bZIP transcription factor and that its functions reside in the cytoplasm.
Genetic interactions between pha-1 and SynMuv genes
We were interested in determining the degree to which the genetic interaction between pha-1 and lin-35 might be interchangeable with other SynMuv genes. Because RNAi inactivation of lin-35 in the pha-1(e2123) mutant background (at 16jC) produced a much higher percentage of Pun larvae than pha-1(fd1) mutants (Table 3) , we used the e2123 allele (at 16jC ) for all interaction tests. In summary, although the penetrance of the Pun phenotypes differed between the genes tested (possibly due to differential responses to RNAi treatment on the individual genes), a clear synthetic phenotype was observed for all class B SynMuv genes tested (Table 3 ). In contrast, the single class A gene tested, lin-15a, showed no sign of an interaction (Table 3) . The class B genes tested included the histone deacetylase hda-1 (Lu and Horvitz, 1998) ; the Mi2 homolog and NURD complex component let-418 (Solari and Ahringer, 2000; von Zelewsky et al., 2000) ; the C. elegans RbAp46/48 homolog, lin-53 (Lu and Horvitz, 1998) ; an E2F homolog, efl-1 (Ceol and Horvitz, 2001) ; and two genes of unknown function, lin-36 (Thomas and Horvitz, 1999) and lin-37 (Boxem and van den Heuvel, 2002) .
This spectrum of genetic interactions was nearly identical to that previously observed for ubc-18 (Fay et al., 2003) . However, in contrast to pha-1, we had not previously detected an interaction between ubc-18 and efl-1. To examine this further, we tested ubc-18 for genetic interactions with efl-1 using the lin-35; ubc-18 double-mutant strain. Previous findings indicated that this strain would provide a more sensitized genetic background than ubc-18(ku354) single mutants [Fay et al., 2003 ; also compare the percentages of Pun animals in lin-35; ubc-18(ku354), lin-35; ubc-18(RNAi), and lin-35; ubc-18(ku354); ubc-18(RNAi) animals, Tables 1 and 3 ]. As shown in Table 3 , inactivation of efl-1 by RNAi dramatically increased the percentage of Pun animals in the lin-35; ubc-18(ku354) double-mutant background, indicating that, like pha-1, efl-1 also shows genetic interactions with ubc-18.
PHA-1 and UBC-18 may regulate a common target
Given the striking similarities in their synthetic phenotypes with lin-35, as well as their matching sets of genetic interactions with other SynMuv genes, it seemed plausible that UBC-18 and PHA-1 might function as co-regulators of a common cellular target. One test of this hypothesis would be to inactivate both genes simultaneously. If UBC-18 and PHA-1 share overlapping functions, then a synthetic genetic interaction would be predicted. Because pha-1 and ubc-18 are located at similar positions on chromosome III (Fay et al., 2003; Granato et al., 1994a) , we inactivated both genes using combinations of genetic mutations and RNAi (Table  2) . In all cases but one, we observed a strong synthetic genetic interaction between ubc-18 and pha-1, leading to a Pun phenotype. This included tests in both wild-type and Fay et al. (2003) . d Experiments were conducted at 20jC. e RNAi of these genes caused significant levels of sterility and embryonic lethality.
lin-35 backgrounds, as well as both the fd1 and e2123 alleles of pha-1. The single exception was pha-1(fd1); ubc-18(RNAi) animals, which probably failed to show an interaction because of the weak nature of the fd1 allele and the incomplete effects of ubc-18(RNAi) (see above and Fay et al., 2003) . We note that because we were limited to the use of partial LOF mutations for this study, it was not possible for us to determine whether UBC-18 and PHA-1 work in tandem or parallel pathways. Nevertheless, these results do indicate that PHA-1 and UBC-18 are likely to act on a common target.
As an additional test for functional convergence, we assayed the ability of two previously isolated extrageneic suppressors of pha-1 (sup-36 and sup-37) to rescue the synthetic lethality of lin-35; ubc-18 double mutants (Schnabel et al., 1991) . sup-36 and sup-37 were previously shown to suppress the lethal phenotype of multiple strong LOF alleles in pha-1, indicating that they are very unlikely to be informational-type suppressors. Strikingly, both mutations were able to fully suppress the synthetic lethality of lin-35; ubc-18 double mutants, as well as the lethality observed in pha-1(e2123); lin-35(RNAi) and in pha-1(e2123); ubc-18(RNAi) mutants (at 16jC). In contrast, neither mutation suppressed the expression of the SynMuv phenotype of lin-35; lin-15a(RNAi) animals, indicating that the suppressors are specific to the pharyngeal defect and not the lin-35 pathway in general. Taken together, these results strongly support the model that PHA-1 and UBC-18 function as dual regulators of a single molecular process.
Discussion
A weak loss-of-function mutation in pha-1 reveals an underlying genetic redundancy
In this report, we have described a synthetic genetic interaction between LOF mutations in lin-35 and pha-1. Although both lin-35(n745) and pha-1(fd1) single mutants are viable and generally appear indistinguishable from wild type, the large majority of double mutants arrest in early larval development with variable defects in pharyngeal development ( Fig. 1; Table 1 ). However, whereas null mutations in lin-35 show no obvious defects (Lu and Horvitz, 1998) , strong LOF mutations in pha-1 lead to a highly penetrant embryonic and larval lethality (Granato et al., 1994a; Schnabel and Schnabel, 1990) . Thus, the genetic redundancy between lin-35 and pha-1 is revealed only through mutations or treatments (i.e., RNAi) that lead to a partial reduction in PHA-1 activity.
It is interesting to note that of the two mutations we have previously reported to show synthetic genetic interactions with lin-35 [fzr-1(ku298) and ubc-18(ku354)], both resulted in partial LOF mutations in the affected genes (Fay et al., 2002 (Fay et al., , 2003 . Moreover, in the case of fzr-1, RNAi injection experiments suggested that a null mutation in fzr-1 may produce a sterile phenotype (Fay et al., 2002) . Therefore, the detection of a genetic interaction between lin-35 and fzr-1, like pha-1, may have been contingent upon our ability to isolate partial LOF mutations in this gene. These findings underscore the versatility and continued importance of this forward-genetic approach. They also indicate that functional redundancy is not merely a property associated with genes that cannot be mutated to an obvious visible phenotype, such as lin-35. The reality is more likely that most genes function in a variety of biological processes, only some of which can be discerned through the study of single mutations.
Cell proliferation, differentiation, or morphogenesis?
Several lines of evidence indicate that the morphogenetic defects observed in lin-35; pha-1 and lin-35; ubc-18 double mutants are not the direct result of cell cycle perturbations. One piece of evidence comes from our analyses of pha-1 and ubc-18 genetic interactions with class B SynMuv genes (Table 3 and Fay et al., 2003) . Namely, both pha-1 and ubc-18 showed genetic interactions with many class B SynMuv genes that were previously shown not to play a role in cell cycle control (Boxem and van den Heuvel, 2002) . At the same time, our current analysis did detect an interaction for both pha-1 and ubc-18 with E2F, a protein with wellcharacterized cell cycle functions. As discussed in the Introduction, however, E2F transcriptional targets include many genes that are not connected to cell cycle control (Dimova et al., 2003; Ishida et al., 2001; Muller et al., 2001) , and there is precedent for non-cell-cycle functions of E2F in both Xenopus and C. elegans (Page et al., 2001; Suzuki and Hemmati-Brivanlou, 2000) . In addition, neither cyclin-D nor cdk4 is required for progression through embryonic cell cycles in C. elegans (Boxem and van den Heuvel, 2001; Park and Krause, 1999) . Given that these two proteins are the principal upstream regulators of Rb in cell cycle regulation, these results indicate that in C. elegans, the Rb pathway is not controlling embryonic divisions. Finally, the phenotypes of lin-35; ubc-18 and lin-35; pha-1 double mutants are not suggestive of defects in cell cycle control (e.g., these mutants do not undergo supernumerary divisions).
We also obtained strong evidence that terminal differentiation of multiple pharyngeal cell types takes place in both lin-35; pha-1 and lin-35; ubc-18 double-mutant animals (this study and Fay et al., 2003) . In addition, through our analysis of the strong LOF mutation, pha-1(e2123), we found that differentiation of pharyngeal epithelial and muscle cells may occur to a greater extent than earlier reports had suggested (Figs. 1G, H and data not shown) . However, we note that we did find evidence for a subtle but reproducible delay in the timing of differentiation of pharyngeal epithelial cells in both lin-35 and pha-1(e2123) (at 25jC) single mutants (based on the ajm-1::GFP marker; data not shown). However, given that neither of these single mutants is defective at early steps of pharyngeal morphogenesis, it is unclear as to how this delay might be relevant to the observed defects in the double mutants.
Complementary pathways controlling organ morphogenesis in C. elegans
We have now shown that three genes, lin-35, ubc-18, and pha-1, function in a partially redundant manner to control pharyngeal morphogenesis during C. elegans embryonic development (Tables 1 and 2 ; Fay et al., 2003) . Four pieces of evidence indicate that the activities of these genes converge on a common cellular target (or set of targets).
(1) The developmental defects of lin-35; ubc-18 and lin-35; pha-1 double mutants are essentially indistinguishable. (2) ubc-18 and pha-1 are identical with respect to their genetic interactions with SynMuv genes. (3) ubc-18 and pha-1 are themselves synthetically lethal and display a Pun phenotype that appears identical to that of lin-35; ubc-18 and lin-35; pha-1 double mutants (Table 2 and data not shown). (4) Mutations that can suppress the lethality of strong LOF mutations in pha-1 also suppress the lethality of lin-35; ubc-18 double mutants. It is tempting to speculate that these suppressor mutations may in fact directly affect the mutual target(s) of LIN-35, UBC-18, and PHA-1 or may occur in genes that are required for the activation of a common target (Fig. 5 and also see below) .
We have previously suggested a model to explain the functional redundancy of lin-35 and ubc-18 (Fay et al., 2003) . The model is based on our current understanding of the principal functions carried out by Rb family proteins and ubiquitin-conjugating enzymes. Namely, LIN-35, a presumed negative regulator of transcription, and UBC-18, a component of the ubiquitin-mediated proteolysis pathway, would share in common one or more cellular targets (Fig. 5A ). In the absence of either LIN-35 or UBC-18 activity (but not both), sufficient negative regulation of the mutual target could be brought about through either pathway acting alone. In the double mutant, however, two principal means of regulation have now been abolished, and the activity of the target would go largely unchecked. More specifically, since both LIN-35 and UBC-18 would be expected to affect the overall abundance of the target protein (vs. its inherent activity), the simultaneous loss of both pathways would lead to the overexpression of the shared target. This model is especially attractive since we have previously obtained evidence that LIN-35 and FZR-1, a conserved component of the anaphase-promoting complex (a multisubunit ubiquitin ligase), cooperate to negatively regulate the levels of G1 cyclins (Fay et al., 2002) .
Where PHA-1 may fit into this process is currently unclear. The initial characterization of pha-1 identified a weak homology to bZIP transcription factors. However, based on the expression pattern of a functional PHA-1::GFP fusion protein (Fig. 4) , as well as our computational analysis of the peptide sequence (see Results), we believe that this is unlikely to be the case. Moreover, because PHA-1 does not contain any known motifs to suggest a biochemical function, we can only speculate at present as to how PHA-1 may intersect with the LIN-35 and UBC-18 pathways to control pharyngeal morphogenesis. Our genetic analysis (Table 2 ) currently supports a model whereby PHA-1 could act either in the same pathway as UBC-18 or through some independent mechanism (Fig. 5A) . In the case of LIN-35 and UBC-18, targets are presumed to be regulated through transcriptional inhibition and ubiquitinmediated proteolysis, respectively. The biochemical function of PHA-1 is not known. Genetic analyses indicate that PHA-1 could act either in a proteolytic pathway with UBC-18 (indicated by the dashed double-headed arrow) or through an independent mechanism. Note that the equal size of the triangles is not meant to suggest that LIN-35, UBC-18, and PHA-1 regulate similar numbers of independent targets. (B, C) Two potential regulatory circuits to account for the observed genetic interactions of lin-35, ubc-18, pha-1, sup-36, and sup-37. In panel B, LIN-35, UBC-18, and PHA-1 converge on a single regulatory target (SUP-37), which if present at high levels inhibits pharyngeal morphogenesis. In this scenario, SUP-36 functions as an upstream activator of SUP-37 and therefore loss of sup-36 can suppress overexpression of SUP-37. In panel C, LIN-35 and UBC-18 act on distinct subunits of a molecular complex (SUP-36-SUP-37), whereas PHA-1 acts on both subunits. In this scenario, loss of LIN-35 and UBC-18 function would result in the moderate overexpression of both subunits. Given the lethal phenotype of pha-1 strong LOF mutations, PHA-1 is also shown in both panels to affect pharyngeal development/morphogenesis through an independent pathway (dashed line). For additional details, see text.
As mentioned above, two obvious candidates for regulation by are the suppressors, SUP-36 and SUP-37. The rationale is that hypomorphic mutations in the target would be predicted to compensate for an overabundance (or hyperactivity) of the protein product. Alternatively, suppression could occur if the mutation affected an important binding partner of the target (e.g., if the target functions as a heterodimer) or an upstream activator of the target (Figs. 5B, C) . It is also worth pointing out that LIN-35 and UBC-18 could be acting independently on different members of a heterodimeric protein complex, such that the observed synergy results from the simultaneous mis-expression of both complex subunits (Fig. 5C ). As to the molecular nature of these targets, we can only speculate at present. One possibility, however, is suggested by a recent paper describing the role of the ubiquitin ligase, Smurf1, in the regulation of cell polarity in mammals. Specifically, Smurf1 is recruited to the leading-edge projections of migrating cells by atypical protein kinase C and CDC42-PAR6, where it regulates the actin cytoskeleton through the inhibition of the RhoA GTPase (Wang et al., 2003) . Thus, signaling molecules and other factors that control cell polarity are obvious candidates as targets.
Additional studies will be necessary to determine the function of PHA-1 and to understand how the activities of PHA-1, LIN-35, and UBC-18 are integrated at the molecular level. These studies will lead to a greater understanding of Rb family functions in development and will also provide further insight into the complexities of redundant cellular mechanisms.
